Teleflex Incorporated (NYSE:TFX) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Teleflex Incorporated (NYSE:TFX) has received an average rating of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $252.50.

Several research analysts have commented on TFX shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Mizuho lowered their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada reduced their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Truist Financial cut their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th.

Institutional Trading of Teleflex

A number of institutional investors have recently modified their holdings of the business. Boston Trust Walden Corp raised its position in Teleflex by 3.9% in the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company’s stock worth $52,435,000 after acquiring an additional 11,052 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its stake in shares of Teleflex by 48.3% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,250 shares of the medical technology company’s stock worth $400,000 after purchasing an additional 733 shares during the period. Robeco Institutional Asset Management B.V. increased its holdings in shares of Teleflex by 1,401.5% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 41,726 shares of the medical technology company’s stock valued at $7,426,000 after purchasing an additional 38,947 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Teleflex in the fourth quarter valued at about $64,000. Finally, Blue Trust Inc. boosted its holdings in Teleflex by 51.0% during the fourth quarter. Blue Trust Inc. now owns 471 shares of the medical technology company’s stock worth $84,000 after buying an additional 159 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Stock Up 0.1 %

Shares of NYSE:TFX opened at $180.95 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex has a fifty-two week low of $171.69 and a fifty-two week high of $256.85. The stock has a market cap of $8.40 billion, a price-to-earnings ratio of 35.97, a price-to-earnings-growth ratio of 1.79 and a beta of 1.16. The firm’s 50 day moving average price is $182.85 and its 200 day moving average price is $214.37.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.64 EPS. As a group, equities research analysts predict that Teleflex will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date was Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.